Longitudinal data suggest that patients with pathogenic variants in GRN experience faster brain atrophy progression than those with pathogenic variants in C9orf72, indicating different rates of pathological progression and fundamental mechanisms associated with different gene variants [10, 20]. The gene discussed is C9orf72; the disease is Brain atrophy.